Volume control and left ventricular hypertrophy in patients with end-stage renal disease

被引：0
|
作者：
De Francisco, ALM [1 ]
Piñera, C [1 ]
机构：
[1] Hosp Univ Valdecilla, Serv Nefrol, Santander, Spain
来源：
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS | 2004年 / 27卷 / 02期
关键词：
D O I：
10.1177/039139880402700202
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：83 / 87
页数：5
相关论文
共 50 条
  • [21] Eccentric Left Ventricular Hypertrophy and Sudden Death in Patients with End-Stage Kidney Disease
    van Zuijdewijn, Camiel L. M. de Roij
    Hansildaar, Romy
    Bots, Michiel L.
    Blankestijn, Peter J.
    van den Dorpel, Marinus A.
    Grooteman, Muriel P. C.
    Kamp, Otto
    ter Wee, Piet M.
    Nube, Menso J.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2015, 42 (02) : 126 - 133
  • [22] Left ventricular volume reduction for end-stage heart disease
    Vanelli, P
    Beretta, L
    Fundarò, PM
    Carro, C
    Santoli, C
    Mangini, A
    Condemi, AR
    Castelli, P
    Munari, M
    [J]. JOURNAL OF CARDIAC SURGERY, 1999, 14 (01) : 60 - 63
  • [23] Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis
    Sato, A
    Takita, T
    Saruta, T
    [J]. CIRCULATION, 1997, 96 (08) : 2198 - 2198
  • [24] Assessment of left ventricular mechanical dyssynchrony in patients with end-stage renal disease
    Ishikawa, Masahiro
    Takahashi, Naoto
    Hanaoka, Daisuke
    Kikuchi, Arifumi
    Yamamoto, Eisei
    Amitani, Kenichi
    Uchida, Takahiro
    Sato, Naoki
    Munakata, Kazuo
    Mizuno, Kyoichi
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [25] Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis
    Sato, A
    Funder, JW
    Saruta, T
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (09) : 867 - 873
  • [26] Prognostic significance of left ventricular dysfunction in end-stage renal disease patients
    Kao, Hung-Men
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 104 - 104
  • [27] Role of aldosterone in left ventricular hypertrophy among African-American patients with end-stage renal disease on hemodialysis
    Steigerwalt, Susan
    Zafar, Abida
    Mesiha, Nancy
    Gardin, Julius
    Provenzano, Robert
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2007, 27 (02) : 159 - 163
  • [28] Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease
    Osono, E
    Kurihara, S
    Hayama, N
    Sakurai, Y
    Ohwada, K
    Onoda, N
    Takeuchi, M
    Tomizawa, T
    Komaba, Y
    Hashimoto, K
    Matsunobu, S
    Yoneshima, H
    Iino, Y
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) : 725 - 730
  • [29] Interleukin 18 as a New Inflammatory Mediator in Left Ventricular Hypertrophy in Children with End-stage Renal Disease
    Badawy, Ahlam
    Nigm, Dalia A.
    Ezzat, Ghada M.
    Gamal, Yasser
    [J]. SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2020, 31 (06) : 1206 - 1216
  • [30] Low agreement between cardiologists diagnosing left ventricular hypertrophy in children with end-stage renal disease
    Schoenmaker, Nikki J.
    van der Lee, Johanna H.
    Groothoff, Jaap W.
    van Iperen, Gabrielle G.
    Frohn-Mulder, Ingrid M. E.
    Tanke, Ronald B.
    Ottenkamp, Jaap
    Kuipers, Irene M.
    [J]. BMC NEPHROLOGY, 2013, 14
12345